InvestorsHub Logo
Followers 12
Posts 368
Boards Moderated 0
Alias Born 04/27/2003

Re: None

Monday, 05/03/2021 11:59:25 AM

Monday, May 03, 2021 11:59:25 AM

Post# of 233476
Other anti-GPCR mAbs are in late-stage clinical trials or pre-registration, including leronlimab (PRO-140), a humanized anti-CCR5 mAb undergoing regulatory review as a treatment for HIV infection, with additional clinical trials in progress or planned in acute GvHD (Phase 2) and metastatic triple-negative breast cancer (Phase 1b/2). 2,5

https://www.tandfonline.com/doi/full/10.1080/19420862.2020.1755069
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News